Global Cancer Diagnostics Device Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 145901
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 130
  • list Medical Devices

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. 

Scope of the Report:

This report focuses on the Cancer Diagnostics Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2020.

The Americas dominated the global cancer diagnostic devices market in 2015 with a market share of close to 53% and will retain its leadership position until the end of 2020. The Americas region has several well-known medical facilities, which focus on targeted therapeutic methods to treat different types of cancers. The availability of a large number of medical facilities in the Americas will lead to the strong growth of this market over the forecast period.

The worldwide market for Cancer Diagnostics Device is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abbott Diagnostics

Agilent Technologies

BD

bioMérieux

Qiagen

Roche Diagnostics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Companion Diagnostics

Molecular Diagnostics

Market Segment by Applications, can be divided into

Lung

Breast

Colorectal

Prostate

Cervical

Others

There are 15 Chapters to deeply display the global Cancer Diagnostics Device market.

Chapter 1, to describe Cancer Diagnostics Device Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Diagnostics Device, with sales, revenue, and price of Cancer Diagnostics Device, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Diagnostics Device, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Diagnostics Device market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Diagnostics Device sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Cancer Diagnostics Device Introduction

1.2 Market Analysis by Type

1.2.1 Companion Diagnostics

1.2.2 Molecular Diagnostics

1.3 Market Analysis by Applications

1.3.1 Lung

1.3.2 Breast

1.3.3 Colorectal

1.3.4 Prostate

1.3.5 Cervical

1.3.6 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott Diagnostics

2.1.1 Business Overview

2.1.2 Cancer Diagnostics Device Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Diagnostics Cancer Diagnostics Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Agilent Technologies

2.2.1 Business Overview

2.2.2 Cancer Diagnostics Device Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Agilent Technologies Cancer Diagnostics Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 BD

2.3.1 Business Overview

2.3.2 Cancer Diagnostics Device Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BD Cancer Diagnostics Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 bioMérieux

2.4.1 Business Overview

2.4.2 Cancer Diagnostics Device Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 bioMérieux Cancer Diagnostics Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Qiagen

2.5.1 Business Overview

2.5.2 Cancer Diagnostics Device Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Qiagen Cancer Diagnostics Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Roche Diagnostics

2.6.1 Business Overview

2.6.2 Cancer Diagnostics Device Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Roche Diagnostics Cancer Diagnostics Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer Diagnostics Device Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cancer Diagnostics Device Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cancer Diagnostics Device Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cancer Diagnostics Device Manufacturer Market Share in 2017

3.3.2 Top 6 Cancer Diagnostics Device Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cancer Diagnostics Device Market Analysis by Regions

4.1 Global Cancer Diagnostics Device Sales, Revenue and Market Share by Regions

4.1.1 Global Cancer Diagnostics Device Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cancer Diagnostics Device Revenue and Market Share by Regions (2013-2018)

4.2 North America Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

4.3 Europe Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

4.5 South America Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

5 North America Cancer Diagnostics Device by Countries

5.1 North America Cancer Diagnostics Device Sales, Revenue and Market Share by Countries

5.1.1 North America Cancer Diagnostics Device Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cancer Diagnostics Device Revenue and Market Share by Countries (2013-2018)

5.2 United States Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

5.3 Canada Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

5.4 Mexico Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

6 Europe Cancer Diagnostics Device by Countries

6.1 Europe Cancer Diagnostics Device Sales, Revenue and Market Share by Countries

6.1.1 Europe Cancer Diagnostics Device Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cancer Diagnostics Device Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

6.3 UK Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

6.4 France Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

6.5 Russia Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

6.6 Italy Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cancer Diagnostics Device by Countries

7.1 Asia-Pacific Cancer Diagnostics Device Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cancer Diagnostics Device Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cancer Diagnostics Device Revenue and Market Share by Countries (2013-2018)

7.2 China Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

7.3 Japan Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

7.4 Korea Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

7.5 India Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

8 South America Cancer Diagnostics Device by Countries

8.1 South America Cancer Diagnostics Device Sales, Revenue and Market Share by Countries

8.1.1 South America Cancer Diagnostics Device Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cancer Diagnostics Device Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

8.3 Argentina Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

8.4 Colombia Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cancer Diagnostics Device by Countries

9.1 Middle East and Africa Cancer Diagnostics Device Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cancer Diagnostics Device Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cancer Diagnostics Device Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

9.3 UAE Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

9.4 Egypt Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

9.5 Nigeria Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

9.6 South Africa Cancer Diagnostics Device Sales and Growth Rate (2013-2018)

10 Global Cancer Diagnostics Device Market Segment by Type

10.1 Global Cancer Diagnostics Device Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cancer Diagnostics Device Sales and Market Share by Type (2013-2018)

10.1.2 Global Cancer Diagnostics Device Revenue and Market Share by Type (2013-2018)

10.2 Companion Diagnostics Sales Growth and Price

10.2.1 Global Companion Diagnostics Sales Growth (2013-2018)

10.2.2 Global Companion Diagnostics Price (2013-2018)

10.3 Molecular Diagnostics Sales Growth and Price

10.3.1 Global Molecular Diagnostics Sales Growth (2013-2018)

10.3.2 Global Molecular Diagnostics Price (2013-2018)

11 Global Cancer Diagnostics Device Market Segment by Application

11.1 Global Cancer Diagnostics Device Sales Market Share by Application (2013-2018)

11.2 Lung Sales Growth (2013-2018)

11.3 Breast Sales Growth (2013-2018)

11.4 Colorectal Sales Growth (2013-2018)

11.5 Prostate Sales Growth (2013-2018)

11.6 Cervical Sales Growth (2013-2018)

11.7 Others Sales Growth (2013-2018)

12 Cancer Diagnostics Device Market Forecast (2018-2023)

12.1 Global Cancer Diagnostics Device Sales, Revenue and Growth Rate (2018-2023)

12.2 Cancer Diagnostics Device Market Forecast by Regions (2018-2023)

12.2.1 North America Cancer Diagnostics Device Market Forecast (2018-2023)

12.2.2 Europe Cancer Diagnostics Device Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cancer Diagnostics Device Market Forecast (2018-2023)

12.2.4 South America Cancer Diagnostics Device Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cancer Diagnostics Device Market Forecast (2018-2023)

12.3 Cancer Diagnostics Device Market Forecast by Type (2018-2023)

12.3.1 Global Cancer Diagnostics Device Sales Forecast by Type (2018-2023)

12.3.2 Global Cancer Diagnostics Device Market Share Forecast by Type (2018-2023)

12.4 Cancer Diagnostics Device Market Forecast by Application (2018-2023)

12.4.1 Global Cancer Diagnostics Device Sales Forecast by Application (2018-2023)

12.4.2 Global Cancer Diagnostics Device Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cancer Diagnostics Device Picture

Table Product Specifications of Cancer Diagnostics Device

Figure Global Sales Market Share of Cancer Diagnostics Device by Types in

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery